Glassy Mountain Advisors Inc. Acquires 250 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Glassy Mountain Advisors Inc. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,647 shares of the company’s stock after purchasing an additional 250 shares during the period. Glassy Mountain Advisors Inc.’s holdings in HCA Healthcare were worth $2,595,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the third quarter worth approximately $39,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the third quarter worth approximately $41,000. Canoe Financial LP bought a new position in HCA Healthcare in the third quarter worth approximately $41,000. Northwest Investment Counselors LLC bought a new position in HCA Healthcare in the third quarter worth approximately $44,000. Finally, Friedenthal Financial bought a new position in HCA Healthcare in the third quarter worth approximately $50,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. KeyCorp decreased their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $324.33 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The business has a fifty day moving average price of $313.88 and a 200-day moving average price of $353.57. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a market capitalization of $82.15 billion, a P/E ratio of 14.76, a PEG ratio of 1.13 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business earned $5.90 earnings per share. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.89 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.89%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.